[{"NetIncomeLoss_1_Q3_USD":-4124000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":8546000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":51632750.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":54858052.0,"RepaymentsOfLongTermDebt_3_Q3_USD":100000.0,"PaymentsToAcquireLongtermInvestments_3_Q3_USD":1000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":10445000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":6420000.0,"InterestPaidNet_3_Q3_USD":3000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":603000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-2949000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":193831000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":24316000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":193831000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":483000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2543000.0,"AssetsCurrent_0_Q3_USD":370315000.0,"OperatingLeaseExpense_7_Q3_USD":1400000.0,"OperatingLeaseExpense_1_Q3_USD":500000.0,"SellingAndMarketingExpense_3_Q3_USD":39240000.0,"SellingAndMarketingExpense_1_Q3_USD":10955000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":5641543.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":5399174.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":3329000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":8074000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2472000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":3161000.0,"CommonStockSharesIssued_0_Q3_shares":57813833.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"Liabilities_0_Q3_USD":31426000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":12618000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":4042000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":14845000.0,"InventoryWriteDown_3_Q3_USD":1088000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-3300000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":627000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-3000.0,"AccountsReceivableNetCurrent_0_Q3_USD":17629000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":58000.0,"OperatingLeaseLiability_0_Q3_USD":11873000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":5919000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":200684000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":332000.0,"CostsAndExpenses_3_Q3_USD":110264000.0,"CostsAndExpenses_1_Q3_USD":35187000.0,"IncreaseDecreaseInInventories_3_Q3_USD":-1262000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-534000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":3822000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":1274000.0,"OtherAssetsNoncurrent_0_Q3_USD":2303000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":345080000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":10331000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":696217000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":17000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-134000.0,"Assets_0_Q3_USD":454151000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":8094000.0,"CommonStockSharesOutstanding_0_Q3_shares":57813833.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_0_Q3_USD":0.0,"Goodwill_0_Q3_USD":2725000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":3161000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-11972000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2401000.0,"LiabilitiesCurrent_0_Q3_USD":13919000.0,"AccountsPayableCurrent_0_Q3_USD":1932000.0,"InterestExpense_3_Q3_USD":175000.0,"InterestExpense_1_Q3_USD":55000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":345683000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-1742000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3150000.0,"LongTermDebtNoncurrent_0_Q3_USD":756000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":2063000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_3_Q3_USD":13169000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q3_USD":13169000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":2037000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":935000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":61197000.0,"NumberOfOperatingSegments_3_Q3_pure":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":355000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":8914000.0,"NetIncomeLoss_3_Q3_USD":-26865000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":10114000.0,"ShareBasedCompensation_3_Q3_USD":9354000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":185763000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":5279277.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":9886980.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":193831000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":2972000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":2614000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":923000.0,"CommonStockSharesAuthorized_0_Q3_shares":125000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":82947000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":31121000.0,"OperatingIncomeLoss_3_Q3_USD":-27317000.0,"OperatingIncomeLoss_1_Q3_USD":-4066000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-273550000.0,"InventoryNet_0_Q3_USD":4456000.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":454151000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":8382000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1542000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.52,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.08,"StockholdersEquity_0_Q3_USD":422725000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1949000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_3_Q3_USD":728000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_1_Q3_USD":43000.0,"PreferredStockValue_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":588000.0,"Ticker":"VCYT","CIK":"1384101","name":"VERACYTE, INC.","OfficialName":"Veracyte Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1700692789.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201102"}]